Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.

International journal of molecular sciences·2026
Same author

Development of a New Patient-Reported Outcome to Measure Fatigue in Patients with Multiple Sclerosis.

Nursing reports (Pavia, Italy)·2026
Same author

Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.

Journal of clinical medicine·2023
Same author

Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers.

International journal of molecular sciences·2023
Same author

Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies.

Journal of clinical medicine·2022
Same author

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses.

Journal of personalized medicine·2022

Related Experiment Video

Updated: Sep 6, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K

Personalized Diagnosis and Therapy for Multiple Sclerosis.

Cristina Ramo-Tello1

  • 1Hospital Germans Trias i Pujol, Ctra Canyet, s/n, 08916 Badalona, Spain.

Journal of Personalized Medicine
|June 24, 2022
PubMed
Summary
This summary is machine-generated.

This Special Issue focuses on personalized diagnosis and therapy for multiple sclerosis (MS). It presents eight publications to aid clinicians in managing MS patient care effectively.

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.8K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.1K

Related Experiment Videos

Last Updated: Sep 6, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.8K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.1K

Area of Science:

  • Neurology
  • Immunology
  • Medical Research

Background:

  • Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Current management of MS involves a combination of therapeutic strategies and diagnostic approaches.
  • The need for personalized medicine in MS is increasingly recognized to optimize patient outcomes.

Discussion:

  • This Special Issue compiles eight key publications relevant to the clinical practice of multiple sclerosis.
  • The selected articles offer insights into tailored diagnostic methods and therapeutic interventions for MS.
  • The content aims to support clinicians in providing individualized care for individuals with MS.

Key Insights:

  • Personalized diagnosis and therapy are crucial for effective multiple sclerosis management.
  • Advances in understanding MS pathophysiology are enabling more targeted treatment strategies.
  • Clinicians can leverage these publications to enhance their approach to MS patient care.

Outlook:

  • Future research in MS will likely focus on further refining personalized treatment protocols.
  • Continued exploration of novel diagnostic biomarkers and therapeutic targets is anticipated.
  • The integration of personalized approaches promises improved quality of life for individuals with MS.